Its upregulation in a plethora of solid organ tumors, and promising anti-tumor effects when disrupted, especially given its distinct vascular normalization effects, give credence to further investigation into how CD93 acts as an intercellular adhesion molecule and promoter of EC formation. This evidence concerns the gene CD93 and neoplasm.